Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma.
Boccon-Gibod, Clémentine
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. [electronic resource] - British journal of haematology 05 2020 - e73-e76 p. digital
Publication Type: Letter
1365-2141
10.1111/bjh.16483 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Bridged Bicyclo Compounds, Heterocyclic--pharmacology
Dexamethasone--pharmacology
Female
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Neoplasm Recurrence, Local
Oligopeptides--pharmacology
Sulfonamides--pharmacology
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. [electronic resource] - British journal of haematology 05 2020 - e73-e76 p. digital
Publication Type: Letter
1365-2141
10.1111/bjh.16483 doi
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Bridged Bicyclo Compounds, Heterocyclic--pharmacology
Dexamethasone--pharmacology
Female
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Neoplasm Recurrence, Local
Oligopeptides--pharmacology
Sulfonamides--pharmacology